Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment
SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2024--
Source: eagletribune.com
Stay updated with breaking news from Courtr Turner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2024--
San Diego-based Onchilles Pharma said this morning that it has raised $7M in a Series A funding round. The funding came from LYZZ Capital, and also included $500K from the University of Chicago's St